Anzeige
Mehr »
Login
Donnerstag, 20.03.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Nachhaltig und revolutionär - Diese Innovation könnte der nächste Tesla-Moment für Investoren sein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
307 Leser
Artikel bewerten:
(2)

Alpha Genesis, Inc.: Alpha Genesis Whistleblower Documents Exposed as Fabricated Misinformation

Finanznachrichten News

YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / March 19, 2025 / Recent claims made in so-called "whistleblower" documents regarding Alpha Genesis, Inc. have been thoroughly examined and found to be fraudulent. These documents are part of a deliberate misinformation campaign aimed at discrediting a well-respected research institution known for its commitment to ethical practices, scientific integrity, and regulatory compliance. The reckless dissemination of these falsehoods not only misleads the public but also threatens to undermine legitimate biomedical research and the rigorous ethical standards that govern it.

The alleged documents, which purport to expose misconduct at the Alpha Genesis Primate Research Center, contain numerous inconsistencies, unverifiable claims, and clear indications of intentional deception. Upon closer examination, it is evident that the claims presented are not supported by factual evidence and were deliberately crafted to manipulate public perception. Despite efforts to tarnish the company's reputation, the facts remain indisputable:

  • Alpha Genesis, Inc. operates under strict regulatory oversight, including compliance with the U.S. Department of Agriculture (USDA) and other governing bodies.

  • The company adheres to the highest standards of animal welfare and follows all ethical research practices outlined by federal and international regulatory agencies.

  • Independent audits and inspections confirm ongoing compliance with all industry regulations, ensuring transparency and accountability in all research activities.

In response to these baseless allegations, a spokesperson for Alpha Genesis stated:

"The reckless circulation of falsified documents is nothing more than an attempt to mislead the public and attack a facility that plays a crucial role in advancing scientific and medical research. Alpha Genesis remains fully committed to transparency, compliance, and the highest ethical standards. We will not allow baseless accusations to go unchallenged."

This situation serves as a stark reminder of the dangers of misinformation campaigns that seek to erode public trust in critical research institutions. In recent years, numerous organizations worldwide have been targeted by similar deceptive tactics, often resulting in unwarranted skepticism toward legitimate research efforts. Such misleading narratives not only threaten scientific progress but also jeopardize the development of life-saving medical advancements.

Alpha Genesis urges media outlets, policymakers, and the general public to remain vigilant against the spread of misinformation. It is essential to rely on verifiable facts and credible sources when assessing claims about research institutions. Responsible journalism and fact-checking are more critical than ever to ensure that the integrity of scientific research is not compromised by reckless and misleading allegations.

Furthermore, those who fabricate and distribute false claims must be held accountable for their role in spreading misinformation. The public deserves accurate, evidence-based information about biomedical research and the institutions that support it.

Contact Information

Dr. Greg Westergaard
President and CEO
gwprimate@alphagenesisinc.com
843-589-5190

.

SOURCE: Alpha Genesis, Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.